Wilkinson Royce A, Evans Jody R, Jacobs Jon M, Slunaker Dustin, Pincus Seth H, Pinter Abraham, Parkos Charles A, Burritt James B, Teintze Martin
Departments of Chemistry, Montana State University, Bozeman, Montana 59717-3400, USA.
AIDS Res Hum Retroviruses. 2007 Nov;23(11):1416-27. doi: 10.1089/aid.2007.0027.
Monoclonal antibodies specific for the conserved CD4 binding site region of the HIV envelope protein gp120 were used to select phage from two different random peptide display libraries. Synthetic peptides were made with sequences corresponding to those displayed on the selected phage, and peptide-protein fusions were expressed that contained the selected phage-displayed peptide sequence and either the N-terminal domain of the phage pIII protein or the small heat shock protein of Methanococcus jannaschii or both. For monoclonal antibody 5145A, these constructs containing the selected peptide sequences were all capable of specifically inhibiting the binding of 5145A to HIV-1 gp120. Rabbits immunized with peptide-protein fusions produced antisera that bound to recombinant HIV-1 gp120, but did not bind to HIV-infected cells nor neutralize HIV. The antisera also did not compete with CD4 or antibodies to the CD4 binding site for binding to gp120.
针对HIV包膜蛋白gp120保守CD4结合位点区域的单克隆抗体被用于从两个不同的随机肽展示文库中筛选噬菌体。合成了与所选噬菌体上展示的序列相对应的肽段,并表达了肽-蛋白融合体,其包含所选噬菌体展示的肽序列以及噬菌体pIII蛋白的N端结构域或詹氏甲烷球菌的小热休克蛋白或两者。对于单克隆抗体5145A,这些包含所选肽序列的构建体均能够特异性抑制5145A与HIV-1 gp120的结合。用肽-蛋白融合体免疫的兔子产生的抗血清能与重组HIV-1 gp120结合,但不与HIV感染细胞结合,也不能中和HIV。该抗血清也不与CD4或CD4结合位点抗体竞争与gp120的结合。